UK +44 (0)1223 491486      USA toll free 1-866 877 2185

Qkine appoints Japanese distribution partner MBL to extend global availability of its innovative stem cell and organoid culture reagents

Qkine has concluded a sales distribution agreement with Japanese company, MBL Medical & Biological Laboratories Co., Ltd. MBL have extensive knowledge and presence within the Japanese regenerative medicine and iPSC sector, an important market for Qkine's high purity, animal-free optimised growth factor and cytokine proteins. The two companies share a focus on product quality and the emerging areas of organoid and organ-on-chip technologies for basic research, personalised medicine and drug discovery. This distributor agreement between Qkine and MBL will facilitate access to Qkine's entire range of premium quality, animal-free and novel optimised growth factor proteins across Japan.

By |2021-10-08T12:15:37+00:00October 8th, 2021|animal-free, news, organoid news|Comments Off on Qkine appoints Japanese distribution partner MBL to extend global availability of its innovative stem cell and organoid culture reagents

Revenge of the Organoids – Super Scientist saves the day

Can Super Scientist give you your organoid mojo back? Are your growth factors the reason your experiments fail? Can you use engineered or niche-specific growth factors to improve your organoid culture? Super Scientist flies in with easy fixes and questions to ask yourself - do you need to ditch the conditioned media, play around with growth factor combinations, switch noggin and gremlin, or be bold and explore new engineered proteins.

By |2021-09-20T20:15:43+00:00September 20th, 2021|#qkinetechtip, organoid news, protein engineering, resources|Comments Off on Revenge of the Organoids – Super Scientist saves the day

Qkine, with UK biotechnology companies Manchester BIOGEL and Cellesce, is developing fully synthetic animal-free scaffolds to overcome barriers in sustainable and scalable organoid culture, in a project funded by Innovate UK

Qkine, Manchester BIOGEL and Cellesce have been awarded Innovate UK Sustainable Innovation Funding to develop fully synthetic, chemically-defined three-dimensional (3D) scaffolds to enable manufacture scale up and improve reproducibility of patient-derived organoids.

By |2020-11-25T15:00:51+00:00November 25th, 2020|animal-free, news, organoid news|Comments Off on Qkine, with UK biotechnology companies Manchester BIOGEL and Cellesce, is developing fully synthetic animal-free scaffolds to overcome barriers in sustainable and scalable organoid culture, in a project funded by Innovate UK

Organoid Q&A with industry experts from the HUB, CSHL and Stemnovate

We recently held a webinar with CytoSMART and organoid pioneers from Cold Spring Harbor Laboratory, Stemnovate and the Hubrecht Organoid Technology titled: what's needed to realize the potential of organoids? Following presentations from our speakers, we held an insightful Q&A session to address key challenges and questions from the audience. In this blog post, [...]

By |2020-12-08T16:33:07+00:00November 9th, 2020|organoid news, quality, resources|Comments Off on Organoid Q&A with industry experts from the HUB, CSHL and Stemnovate

On-demand webinar: What’s needed to realise the potential of organoids?

From standardization of imaging techniques, to more reproducible and cost-effective organoid culture media Organoids have the potential to revolutionize current drug discovery approaches, enhance the physiological relevance of in vitro disease models, and deliver on the promise of precision medicine. But, as with any new technology, there are a number of hurdles to overcome as [...]

By |2020-11-10T16:07:01+00:00October 14th, 2020|organoid news, quality, resources|Comments Off on On-demand webinar: What’s needed to realise the potential of organoids?

Building next generation growth factors for organoid-driven precision medicine: a protein engineering project co-funded by Innovate UK

We were delighted to be awarded Innovate UK funding to address issues of quality and availability of growth factors for use in organoid technologies. The Qkine R&D team are applying a combination of protein expression, refolding optimisation and structure-guided protein engineering to improve the biological properties and quality of proteins such as R-spondins, TGFβ1, members of the BMP and FGF family proteins.

By |2020-08-25T09:50:27+00:00May 8th, 2018|news, organoid news, protein engineering|Comments Off on Building next generation growth factors for organoid-driven precision medicine: a protein engineering project co-funded by Innovate UK

Title

Go to Top